The 2nd European Lung Cancer Conference held in partnership with the European Society for Medical Oncology (ESMO) and International Association for the Study of Lung Cancer (IASLC) has been a resounding success.  This year there was record attendance with 1,700 participants from 78 countries.  The comprehensive Conference program addressed real clinical situations and demonstrated the underlying need for multidisciplinary collaboration in the treatment of lung cancer.

Educational sessions on important topics presented by the world's leading authorities were complemented by debates on controversial topics, specialty-specific workshops and in-depth Meet-the-Professor sessions with a focus on clinically relevant issues facing oncologists in their daily practice.  In order to keep abreast of the latest developments in basic, clinical and translational research, the 2nd European Lung Cancer Conference was THE thoracic CME conference to attend.

Daily Highlights Abstract book Webcast